NTLA Operating Cash Flow (Statement)
Intellia Therapeutics Inc · Operating Cash Flow (Statement)
NTLA Operating Cash Flow (Statement)
Latest reported-$346.64Mperiod ending
NTLA Cash from Operations (-$3.48M → -$346.64M)
Annual operating cash flow (statement)
High-resolution chart · PNG
NTLA operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -348,880,000 | |
| -348,880,000 | |
| -394,086,000 | |
| -333,287,000 | |
| -225,030,000 | |
| -49,912,000 | |
| -103,240,000 | |
| -61,257,000 | |
| -65,276,000 | |
| 36,109,000 | |
| -1,763,000 | |
| -3,483,000 |